Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

2021 ◽  
Author(s):  
Andrew Bottomley ◽  
Corneel Coens ◽  
Justyna Mierzynska ◽  
Christian U Blank ◽  
Mario Mandalà ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Health Related Quality ◽  
Phase 3 ◽  
Double Blind ◽  
Related Quality ◽  
Health Related ◽  
Stage Iii Melanoma ◽  
Resected Stage ◽  
Randomised Controlled

scholarly journals Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies

2018 ◽  
Vol 13 (1) ◽  
pp. 139-140 ◽  
Author(s):  
Julian Panés ◽  
Séverine Vermeire ◽  
James O Lindsay ◽  
Bruce E Sands ◽  
Chinyu Su ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Ulcerative Colitis ◽  
Health Related Quality ◽  
Phase 3 ◽  
Related Quality ◽  
Health Related ◽  
Randomised Controlled

scholarly journals Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies

2017 ◽  
Vol 12 (2) ◽  
pp. 145-156 ◽  
Author(s):  
Julian Panés ◽  
Séverine Vermeire ◽  
James O Lindsay ◽  
Bruce E Sands ◽  
Chinyu Su ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Ulcerative Colitis ◽  
Health Related Quality ◽  
Phase 3 ◽  
Related Quality ◽  
Health Related ◽  
Randomised Controlled

scholarly journals Health-Related Quality of Life as Measured by the 36-item Short Form Survey Among Adults with Acute Bacterial Skin and Skin Structure Infections Who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial

2021 ◽  
Author(s):  
Surya Chitra ◽  
Jordan Hinahara ◽  
Thomas F Goss ◽  
Kyle Gunter ◽  
Kenneth LaPensee
Keyword(s):  
Quality Of Life ◽  
Short Form ◽  
Oral Treatment ◽  
Health Related Quality ◽  
Phase 3 ◽  
Double Blind ◽  
Skin Structure ◽  
Related Quality ◽  
Health Related

Abstract This analysis of data from a Phase 3 study of adults with acute bacterial skin and skin structure infections showed that successful oral treatment with omadacycline (n=368) or linezolid (n=367) was associated with improvement in health-related quality of life.

Sign in / Sign up

Export Citation Format

Share Document